EXCLUSIVE: Zash Chair Says Co. Not Planning To Do An Offering
https://www.youtube.com/watch?v=_eiGsJgpmNg
HEXO Stock Plunges On $140M Public Offering Announcement Ahead Of Transfer To NASDAQ
HEXO Corp (TSX: HEXO) (NYSE: HEXO) announced Friday the pricing of a previously announced overnight marketed public offering of its 47.46 million units at a price of $2.95 per unit.
Sonnet BioTherapeutics Stock Slumps After $30M Equity Raise
Sonnet BioTherapeutics Holdings Inc (NASDAQ: SONN) priced the underwritten public offering of 35.3 million shares (including pre-funded warrants) and warrants to purchase up to 35.3 million shares.
Why HEXO’s Stock Is Getting Hammered Today
HEXO Corp (NYSE: HEXO) shares are trading lower by 20% at $2.56 after the company announced a proposed public offering.
NewLake Capital Partners Debuts On OTCQX Best Market, Closes $101.6M IPO, Increasing Cannabis Dispensary and Cultivation Portfolio
NewLake Capital Partners, Inc (OTCQX: NLCP), a sale-leaseback real estate company for the cannabis industry, began trading on the OTCQX Best Market under symbol NLCP on Friday, August 20.
HEXO Corp. Announces $140M Public Offering Prices $2.95/Unit
HEXO Corp. Announces US$140 Million Public Offering
OTTAWA, Aug. 20, 2021 (GLOBE NEWSWIRE) -- HEXO Corp ("HEXO" or the "Company") (TSX:HEXO, NYSE:HEXO) today announced the pricing of its previously
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen’s Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 19)
Progenity Announces Proposed Underwritten Public Offering of Common Stock and Warrants
Progenity, Inc. ("Progenity") (NASDAQ:PROG), an innovative biotechnology company, announced today that it intends to offer and sell, subject to market and other conditions, shares of its common stock and